Revisiting the Total Hildebrand and Partial Hansen Solubility Parameters of Analgesic Drug Meloxicam

Author:

Tinjacá Darío A.1ORCID,Martinez Fleming2ORCID,Peña María Angeles3ORCID,Jouyban Abolghasem45ORCID,Acree William E.6ORCID

Affiliation:

1. Facultad de Ciencias, Universidad El Bosque, Av. Cra. 9 No. 131A-02, Bogotá 110121, Colombia

2. Grupo de Investigaciones Farmacéutico-Fisicoquímicas, Departamento de Farmacia, Facultad de Ciencias, Universidad Nacional de Colombia, Sede Bogotá, Cra. 30 No. 45-03, Bogotá 111321, Colombia

3. Departamento de Ciencias Biomédicas, Facultad de Farmacia, Universidad de Alcalá, Alcalá de Henares, 28054 Madrid, Spain

4. Pharmaceutical Analysis Research Center and Faculty of Pharmacy, Tabriz University of Medical Sciences, Tabriz 5165665811, Iran

5. Faculty of Pharmacy, Near East University, North Cyprus Via Mersin 10, Nicosia 99138, Turkey

6. Department of Chemistry, University of North Texas, Denton, TX 76203-5070, USA

Abstract

The reported total Hildebrand solubility parameter (δ2) value of meloxicam, as calculated based on the group contribution method proposed by Fedors, was compared with those estimated based on the maximum solubility peaks observed in different aqueous cosolvent systems at T = 298.15 K. Thus, the observed δ2 values varied from (19.8 to 29.1) MPa1/2, respectively. Moreover, the Hansen solubility parameters (HSPs) and the total Hildebrand solubility parameter were also determined by using the Bustamante regression method with the reported experimental solubility values of meloxicam in 31 neat solvents (30 organic solvents and water), obtaining the values: δd = 19.9 MPa1/2, δp = 16.9 MPa1/2, δh = 5.7 MPa1/2, and δT = 26.7 MPa1/2. Furthermore, the HSPs of meloxicam were also estimated based on the Hoftyzer–van Krevelen group contribution method, obtaining the values: δd = 17.9 MPa1/2, δp = 20.3 MPa1/2, and δh = 9.2 MPa1/2, and the total solubility parameter as: δT = 28.6 MPa1/2. In addition, the Kamlet–Abboud–Taft linear solvation energy relationship (KAT-LSER) model was also employed to evaluate the role of different intermolecular interactions on the dissolution of meloxicam in different solvents that varied in terms of polarity and hydrogen bonding capability.

Funder

Minciencias

Publisher

MDPI AG

Subject

General Medicine

Reference68 articles.

1. Budavari, S., O’Neil, M.J., Smith, A., Heckelman, P.E., Obenchain, J.R., and Gallipeau, J.A.R. (2001). The Merck Index: An Encyclopedia of Chemicals, Drugs, and Biologicals, Merck & Co., Inc.. [13th ed.].

2. Non steroidal anti-inflammatory drugs—Differences and similarities;Brooks;N. Engl. J. Med.,1991

3. Anti-inflammatory, analgesic, antipyretic and related properties of meloxicam, a new non-steroidal anti-inflammatory agent with favourable gastrointestinal tolerance;Engelhardt;Inflamm. Res.,1995

4. A review of the clinical pharmacokinetics of meloxicam;Roth;Br. J. Rheumatol.,1996

5. Sweetman, S.C. (2009). Martindale: The Complete Drug Reference, Pharmaceutical Press. [36th ed.].

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3